secwatch / observer

Executive movement radar

Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.

Launch 75357 grounded facts newest July 13, 2026, 5:54 PM ET RSS · JSON

Showing 3901–3950 of 75357

Departed

Marsha H. Fanucci

Director
Syros Pharmaceuticals, Inc.
Effective
2025-02-28
Filed
February 28, 2025, 6:59 PM ET
On February 28, 2025, each of Peter Wirth, Marsha H. Fanucci, and Nancy Simonian, M.D., notified the Board of such director’s resignation from the Board and all committees or subcommittees thereof, effective immediately.
Departed

Nancy Simonian

Director
Syros Pharmaceuticals, Inc.
Effective
2025-02-28
Filed
February 28, 2025, 6:59 PM ET
On February 28, 2025, each of Peter Wirth, Marsha H. Fanucci, and Nancy Simonian, M.D., notified the Board of such director’s resignation from the Board and all committees or subcommittees thereof, effective immediately.
Departed

Peter Wirth

Director
Syros Pharmaceuticals, Inc.
Effective
2025-02-28
Filed
February 28, 2025, 6:59 PM ET
On February 28, 2025, each of Peter Wirth, Marsha H. Fanucci, and Nancy Simonian, M.D., notified the Board of such director’s resignation from the Board and all committees or subcommittees thereof, effective immediately.
Departed

Manuel A. Fernandez

Director
LEG · LEGGETT & PLATT INC
Effective
2025-05-07
Filed
February 28, 2025, 6:59 PM ET
On February 25, 2025, Mark A. Blinn and Manuel A. Fernandez each notified the Company of their respective decisions to retire as a director of the Company effective immediately prior to the beginning of the 2025 annual shareholder meeting, which currently is expected to be held on May 7, 2025.
Departed

Mark A. Blinn

Director
LEG · LEGGETT & PLATT INC
Effective
2025-05-07
Filed
February 28, 2025, 6:59 PM ET
On February 25, 2025, Mark A. Blinn and Manuel A. Fernandez each notified the Company of their respective decisions to retire as a director of the Company effective immediately prior to the beginning of the 2025 annual shareholder meeting, which currently is expected to be held on May 7, 2025.
Departed

Adam Gallistel

Director
STORE CAPITAL LLC
Effective
2025-02-24
Filed
February 28, 2025, 6:59 PM ET
Effective February 24, 2025, each of Adam Gallistel and Michael Reiter resigned from all positions that he held at STORE Capital LLC (the “ Company ”) and its subsidiaries, including as a member of the Board of Directors (the “ Board ”).
Departed

Michael Reiter

Director
STORE CAPITAL LLC
Effective
2025-02-24
Filed
February 28, 2025, 6:59 PM ET
Effective February 24, 2025, each of Adam Gallistel and Michael Reiter resigned from all positions that he held at STORE Capital LLC (the “ Company ”) and its subsidiaries, including as a member of the Board of Directors (the “ Board ”).
Departed

Tirdad Rouhani

President
ISPR · Ispire Technology Inc.
Effective
2025-02-27
Filed
February 28, 2025, 6:59 PM ET
Mr. Tirdad Rouhani is no longer President of Ispire Technology Inc. (the “Company”) or otherwise employed by the Company or any of the Company’s subsidiaries or affiliates, effective February 27, 2025.
Departed

Ralph Schiess

Interim Chief Executive Officer and Chief Science Officer
ONCO · Onconetix, Inc.
Effective
2025-02-24
Filed
February 28, 2025, 6:59 PM ET
On February 24, 2025, Dr. Ralph Schiess resigned from his positions as the Interim Chief Executive Officer and Chief Science Officer of Onconetix, Inc. (the “Company”), effective immediately
Departed

Todd Becker

President and Chief Executive Officer and member of the Board of Directors
GPRE · Green Plains Inc.
Effective
2025-03-01
Filed
February 28, 2025, 6:59 PM ET
On February 28, 2025, the Board of Directors of Green Plains Inc. (the “Company”) announced by press release the departure of Todd Becker as President and Chief Executive Officer and member of the Board of Directors (the “Board”) of the Company, effective March 1, 2025.
Departed

Heather Planishek

Chief Accounting Officer
PLTR · Palantir Technologies Inc.
Effective
2025-02-25
Successor
Jeffrey Buckley
Filed
February 28, 2025, 6:59 PM ET
following the resignation of Heather Planishek as Chief Accounting Officer of the Company.
Departed

Tracy M. French

Chairman of the Board and Director
HOMB · HOME BANCSHARES INC
Effective
2025-04-17
Filed
February 28, 2025, 6:59 PM ET
he will not stand for reelection as a director of the Company and as Chairman of the Board and a director of the Bank upon the completion of his current term on the Company’s and the Bank’s boards of directors on April 17, 2025
Departed

Melanie M. Kennedy

Executive Vice President and Chief Human Resources Officer
AWK · American Water Works Company, Inc.
Effective
2025-03-01
Filed
February 28, 2025, 6:59 PM ET
On February 28, 2025 , the Executive Development and Compensation Committee of the Board of Directors of American Water Works Company, Inc. (the “Company”) unanimously approved a Severance Agreement and General Release (the “Severance Agreement”) to be entered into between Melanie M. Kennedy, the Company’s Executive Vice President and Chief Human Resources Officer, and American Water Works Service Company, Inc., a wholly owned subsidiary of the Company and Ms. Kennedy’s employer.
Departed

Michael Sousa

Executive Vice President, Enterprise Applications
HSTM · HEALTHSTREAM INC
Effective
2025-03-31
Filed
February 28, 2025, 6:59 PM ET
On February 24, 2025, HealthStream, Inc. (the “Company”) received notice that Michael Sousa, Executive Vice President, Enterprise Applications intends to resign from his current position at the Company effective March 31, 2025.
Departed

Douglas R. Jamieson

Chief Executive Officer and President
ACGP · Associated Capital Group, Inc.
Effective
2025-03-17
Successor
Patrick Huvane
Filed
February 28, 2025, 6:59 PM ET
On February 28, 2025, Associated Capital Group, Inc. (the “Company”) announced that Douglas R. Jamieson will be retiring as its Chief Executive Officer and President effective March 17, 2025, and will continue in his role as a Director of the Company.
Departed

Arnold Tinter

director and corporate secretary
BRFH · BARFRESH FOOD GROUP INC.
Effective
2025-02-28
Filed
February 28, 2025, 6:59 PM ET
On February 28, 2025, Arnold Tinter resigned as a director and corporate secretary of the Company and its subsidiaries due to his desire to retire from active business pursuits.
Departed

Chris Senanayake

Director
SHPH · Shuttle Pharmaceuticals Holdings, Inc.
Effective
2025-02-28
Filed
February 28, 2025, 6:59 PM ET
each of Milton Brown, Bette Jacobs, Chris Senanayake and Joshua Shafer resigned as directors of the Company
Departed

Milton Brown

Director
SHPH · Shuttle Pharmaceuticals Holdings, Inc.
Effective
2025-02-28
Filed
February 28, 2025, 6:59 PM ET
each of Milton Brown, Bette Jacobs, Chris Senanayake and Joshua Shafer resigned as directors of the Company
Departed

Joshua Shafer

Director
SHPH · Shuttle Pharmaceuticals Holdings, Inc.
Effective
2025-02-28
Filed
February 28, 2025, 6:59 PM ET
each of Milton Brown, Bette Jacobs, Chris Senanayake and Joshua Shafer resigned as directors of the Company
Departed

Bette Jacobs

Director
SHPH · Shuttle Pharmaceuticals Holdings, Inc.
Effective
2025-02-28
Filed
February 28, 2025, 6:59 PM ET
each of Milton Brown, Bette Jacobs, Chris Senanayake and Joshua Shafer resigned as directors of the Company
Departed

Lim P. Nguonly

Director
JMSB · John Marshall Bancorp, Inc.
Effective
2025-03-18
Filed
February 28, 2025, 6:59 PM ET
On February 26, 2025, Lim P. Nguonly, a director of John Marshall Bancorp, Inc. (the “Company”) and John Marshall Bank (the “Bank”), a wholly-owned subsidiary of the Company, notified the Company and the Bank that he will not stand for re-election to the Board of Directors of the Company at its 2025 annual meeting of shareholders and will retire from the Boards of Directors of the Company and the Bank effective at the conclusion of the next Board of Directors meeting to be held on March 18, 2025.
Departed

Rory Riggs

Chief Executive Officer
CBUS · Cibus, Inc.
Effective
2025-02-24
Successor
Peter Beetham
Filed
February 28, 2025, 6:59 PM ET
On February 24, 2025, Rory Riggs resigned as the Chief Executive Officer of Cibus, Inc.
Departed

Dawn Smajstrla

Chief Accounting Officer
Sitio Royalties Corp.
Effective
2025-02-27
Filed
February 28, 2025, 6:59 PM ET
On February 27, 2025, Dawn Smajstrla ceased to serve as Chief Accounting Officer of Sitio Royalties Corp.
Departed

Anthony Querciagrossa

Chief Financial Officer
Pinstripes Holdings, Inc.
Effective
2025-02-28
Successor
Caitlin Schaefer
Filed
February 28, 2025, 6:59 PM ET
As previously reported, on February 17, 2025, Anthony Querciagrossa informed the Board of Directors (the “Board”) of Pinstripes Holdings, Inc. (the “Company”) of his resignation as Chief Financial Officer of the Company, effective February 28, 2025.
Departed

Thomas E. Powell

Executive Vice President and Chief Financial Officer
TFX · TELEFLEX INC
Effective
2025-04-01
Successor
John R. Deren
Filed
February 27, 2025, 6:59 PM ET
who on February 24, 2025 informed the Company that he will retire as Executive Vice President and Chief Financial Officer of the Company, effective April 1, 2025.
Departed

Ziv Shoshani

Director
VSH · VISHAY INTERTECHNOLOGY INC
Effective
2025-05-20
Filed
February 27, 2025, 6:59 PM ET
On February 26, 2025, Ziv Shoshani resigned from the Board of Directors of Vishay Intertechnology, Inc. ("the Company"), effective immediately before the election of directors at the Company’s annual meeting of stockholders on May 20, 2025, in order to devote his full business time and attention to Vishay Precision Group, Inc., which he serves as President and Chief Executive Officer and as a member of the board.
Departed

Mary T. McDowell

Director
ADSK · Autodesk, Inc.
Filed
February 27, 2025, 6:59 PM ET
On February 26, 2025, Mary T. McDowell informed the Board of her intention not to stand for re-election at Autodesk's 2025 Annual Meeting of Stockholders.
Departed

Gary Steele

President, Go-to-Market
CSCO · CISCO SYSTEMS, INC.
Effective
2025-05-12
Filed
February 27, 2025, 6:59 PM ET
On February 27, 2025, Cisco and Gary Steele, President, Go-to-Market of Cisco, agreed to change the effective date of his previously announced resignation from Cisco to May 12, 2025.
Departed

Doug Miller

President and Chief Commercial Officer
CARS · Cars.com Inc.
Effective
2025-02-24
Successor
Lisa Gosselin
Filed
February 27, 2025, 6:59 PM ET
the Company is reporting that Doug Miller, the Company’s President and Chief Commercial Officer is departing from the Company to pursue other opportunities.
Departed

Sherry Aulin

Chief Financial Officer
XENE · Xenon Pharmaceuticals Inc.
Effective
2025-06-30
Filed
February 27, 2025, 6:59 PM ET
On February 24, 2025, Ms. Sherry Aulin notified the Company of her decision to resign as Chief Financial Officer, effective June 30, 2025, for personal reasons.
Departed

Richard Booth

Chief Financial Officer
DH · Definitive Healthcare Corp.
Effective
2025-06-01
Successor
Casey Heller
Filed
February 27, 2025, 6:59 PM ET
The Company previously announced that Richard Booth, the Company’s current CFO, would be departing the Company effective June 1, 2025.
Departed

Bill Wagner

Director
AKAM · AKAMAI TECHNOLOGIES INC
Effective
2025-02-24
Filed
February 27, 2025, 6:59 PM ET
On February 24, 2025, Bill Wagner, a member of the Board of Directors (the “Board”) of Akamai Technologies, Inc. (the “Company”), notified the Company of his intent to resign from the Board, effective immediately, due to his acceptance of a new role as Chief Executive Officer of Semrush Holdings, Inc.
Departed

Jon Kaplan

member of the Board
DRIO · DarioHealth Corp.
Effective
2025-02-24
Filed
February 27, 2025, 6:59 PM ET
On February 24, 2025, Jon Kaplan voluntarily resigned from his position as a member of the Board.
Departed

Leigh Morgan

Director
KYMR · Kymera Therapeutics, Inc.
Filed
February 27, 2025, 6:59 PM ET
On February 24, Leigh Morgan, a member of the Board of Directors (the “Board”) of the Company, the Compensation and Talent Committee of the Board, and a member and chair of the Nominating and Corporate Governance Committee of the Board, informed the Company that she does not intend to stand for reelection at the Company’s 2025 annual meeting of shareholders.
Departed

Joseph Simon

Chief Financial Officer
MC · Moelis & Co
Effective
2025-05-31
Successor
Christopher Callesano
Filed
February 27, 2025, 6:59 PM ET
Mr. Simon provided notice of his resignation on February 25, 2025 and will be leaving the Company at the end of May.
Departed

Ignacio Alvarez

Chief Executive Officer
BPOP · POPULAR, INC.
Effective
2025-06-30
Filed
February 27, 2025, 6:59 PM ET
On February 25, 2025, Ignacio Alvarez announced his retirement as Chief Executive Officer (“CEO”) of Popular, Inc. (“Popular” or the “Corporation”), effective June 30, 2025 (the “Retirement Date”).
Departed

David McJannet

Director
HashiCorp, Inc.
Effective
2025-02-27
Filed
February 27, 2025, 6:59 PM ET
David McJannet, Armon Memaran-Dadgar, Glenn Solomon, Susan St. Ledger, Todd Ford, Sigal Zarmi and David Henshall, each of whom was a director of HashiCorp as of immediately prior to the Effective Time, ceased to be a director of HashiCorp
Departed

Paul Warenski

Other Named Officer
HashiCorp, Inc.
Effective
2025-02-27
Filed
February 27, 2025, 6:59 PM ET
David McJannet, Paul Warenski and Werner Schwok, each of whom was an officer of HashiCorp as of immediately prior to the Effective Time, ceased to be an officer of HashiCorp
Departed

David Henshall

Director
HashiCorp, Inc.
Effective
2025-02-27
Filed
February 27, 2025, 6:59 PM ET
David McJannet, Armon Memaran-Dadgar, Glenn Solomon, Susan St. Ledger, Todd Ford, Sigal Zarmi and David Henshall, each of whom was a director of HashiCorp as of immediately prior to the Effective Time, ceased to be a director of HashiCorp
Departed

David McJannet

Other Named Officer
HashiCorp, Inc.
Effective
2025-02-27
Filed
February 27, 2025, 6:59 PM ET
David McJannet, Paul Warenski and Werner Schwok, each of whom was an officer of HashiCorp as of immediately prior to the Effective Time, ceased to be an officer of HashiCorp
Departed

Sigal Zarmi

Director
HashiCorp, Inc.
Effective
2025-02-27
Filed
February 27, 2025, 6:59 PM ET
David McJannet, Armon Memaran-Dadgar, Glenn Solomon, Susan St. Ledger, Todd Ford, Sigal Zarmi and David Henshall, each of whom was a director of HashiCorp as of immediately prior to the Effective Time, ceased to be a director of HashiCorp
Departed

Glenn Solomon

Director
HashiCorp, Inc.
Effective
2025-02-27
Filed
February 27, 2025, 6:59 PM ET
David McJannet, Armon Memaran-Dadgar, Glenn Solomon, Susan St. Ledger, Todd Ford, Sigal Zarmi and David Henshall, each of whom was a director of HashiCorp as of immediately prior to the Effective Time, ceased to be a director of HashiCorp
Departed

Susan St. Ledger

Director
HashiCorp, Inc.
Effective
2025-02-27
Filed
February 27, 2025, 6:59 PM ET
David McJannet, Armon Memaran-Dadgar, Glenn Solomon, Susan St. Ledger, Todd Ford, Sigal Zarmi and David Henshall, each of whom was a director of HashiCorp as of immediately prior to the Effective Time, ceased to be a director of HashiCorp
Departed

Armon Memaran-Dadgar

Director
HashiCorp, Inc.
Effective
2025-02-27
Filed
February 27, 2025, 6:59 PM ET
David McJannet, Armon Memaran-Dadgar, Glenn Solomon, Susan St. Ledger, Todd Ford, Sigal Zarmi and David Henshall, each of whom was a director of HashiCorp as of immediately prior to the Effective Time, ceased to be a director of HashiCorp
Departed

Werner Schwok

Other Named Officer
HashiCorp, Inc.
Effective
2025-02-27
Filed
February 27, 2025, 6:59 PM ET
David McJannet, Paul Warenski and Werner Schwok, each of whom was an officer of HashiCorp as of immediately prior to the Effective Time, ceased to be an officer of HashiCorp
Departed

Todd Ford

Director
HashiCorp, Inc.
Effective
2025-02-27
Filed
February 27, 2025, 6:59 PM ET
David McJannet, Armon Memaran-Dadgar, Glenn Solomon, Susan St. Ledger, Todd Ford, Sigal Zarmi and David Henshall, each of whom was a director of HashiCorp as of immediately prior to the Effective Time, ceased to be a director of HashiCorp
Departed

Andrew Spaventa

Chair of the Board
Singular Genomics Systems, Inc.
Effective
2025-02-21
Filed
February 27, 2025, 6:59 PM ET
Each of Andrew Spaventa, the Company’s Chief Executive Officer and Chair of the Company’s Board, Eli Glezer, Ph.D., the Company’s Chief Scientific Officer and Dalen Meeter, the Company’s Chief Financial Officer resigned from the Company, effective as of immediately prior to the Effective Time.
Departed

Andrew Spaventa

Chief Executive Officer and Chair of the Board
Singular Genomics Systems, Inc.
Effective
2025-02-21
Successor
Joshua Stahl
Filed
February 27, 2025, 6:59 PM ET
Each of Andrew Spaventa, the Company’s Chief Executive Officer and Chair of the Company’s Board, Eli Glezer, Ph.D., the Company’s Chief Scientific Officer and Dalen Meeter, the Company’s Chief Financial Officer resigned from the Company, effective as of immediately prior to the Effective Time.
Departed

Dalen Meeter

Chief Financial Officer
Singular Genomics Systems, Inc.
Effective
2025-02-21
Filed
February 27, 2025, 6:59 PM ET
Each of Andrew Spaventa, the Company’s Chief Executive Officer and Chair of the Company’s Board, Eli Glezer, Ph.D., the Company’s Chief Scientific Officer and Dalen Meeter, the Company’s Chief Financial Officer resigned from the Company, effective as of immediately prior to the Effective Time.
Departed

Eli Glezer

Chief Scientific Officer
Singular Genomics Systems, Inc.
Effective
2025-02-21
Filed
February 27, 2025, 6:59 PM ET
Each of Andrew Spaventa, the Company’s Chief Executive Officer and Chair of the Company’s Board, Eli Glezer, Ph.D., the Company’s Chief Scientific Officer and Dalen Meeter, the Company’s Chief Financial Officer resigned from the Company, effective as of immediately prior to the Effective Time.

Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.